VSVivienne S. Hau

1. Article · Aug 12, 2026 · ByVivienne S. Hau, MD, PhD BySavannah Demko

   Real-world data emerging on dry AMD, geographic atrophy treatments (opens the original)

   Excerpt · English

   Read excerpt

   Major topics of discussion at this year’s American Society of Retina Specialists annual meeting included real-world data on the treatment of geographic atrophy in dry age-related macular degeneration. “This was huge this year because now we actually have medications that can slow down the progression of geographic atrophy and macular degeneration,” Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson School of Medicine, told Healio in an interview. “We even have better imaging

   Feedback

2. Article · Aug 11, 2026 · ByVivienne S. Hau, MD, PhD BySavannah Demko

   Emerging treatments in wet AMD ‘moving beyond anti-VEGFs’ (opens the original)

   Excerpt · English

   Read excerpt

   In this video, Vivienne S. Hau, MD, PhD, discussed a session presented at the American Society of Retina Specialists annual meeting on emerging durable treatments for wet age-related macular degeneration. “This was really interesting because we talked about several different types of mechanisms, the safety and efficacy, and the long-term duration and how we’re moving beyond basically just anti-VEGFs now onto another phase of treatment for macular degeneration,” Hau, of Kaiser Permanente Be

   Feedback

3. Article · Aug 11, 2026 · ByVivienne S. Hau, MD, PhD BySavannah Demko

   Stem cells show promise in repairing damage in geographic atrophy (opens the original)

   Excerpt · Neutral tone · English

   Read excerpt

   Subretinal injection of human stem cell-derived retinal pigment epithelium yielded promising results in patients with geographic atrophy, according to preliminary data presented at the American Society of Retina Specialists annual meeting. “[This is] some very exciting study data that potentially shows the promise of using stem cells to repair damage in the eyes from these diseases, which we’ve never been able to do before,” Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson S

   Feedback

4. Article · Aug 11, 2026 · ByVivienne S. Hau, MD, PhD BySavannah Demko

   ASRS symposium highlights real-world use of current wet AMD treatments (opens the original)

   Excerpt · English

   Read excerpt

   Vivienne S. Hau, MD, PhD, spoke about a session she moderated at the American Society of Retina Specialists annual meeting on current wet age-related macular degeneration treatments and their use in real-world practice. “This is when it really brings it home and provides some practicality to how retina specialists are using these medications,” Hau, of Kaiser Permanente Bernard J. Tyson School of Medicine, told Healio in a video interview. Disclosures: Hau reports receiving research support f

   Feedback

Last 90 days. Choose a month to open its work.

Named in the text we hold. One piece can cover several.

• Ocular Therapeutix4 pieces
• Eli Lilly4 pieces
• EyePoint Pharmaceuticals4 pieces
• American Society4 pieces